Enhanced antibacterial activity in skin exudates isolated MDR Staphylococcus aureus by γ-Al2O3 nanoparticles

Document Type : Research Paper


1 Biology Department, Faculty of Biological Sciences, Tehran North Branch of Islamic Azad University, Tehran, Iran

2 Department of Biology, Islamic Azad University of Medical Sciences, Tehran, Iran

3 Department of Cell and Molecular Biology, School of Biology, University of Tehran, Tehran, Iran


Objective(s): Staphylococcus aureus is one of the most common causes of infections affecting the skin and soft tissues, which causes many types of syndromes, including skin and soft tissue infections in humans. The quick occurrence of resistance to many antimicrobial substances and severe infections requires long-term intravenous administration of beta-lactamase-resistant Penicillin. 
Materials and Methods: The antimicrobial activity of γ-Al2O3 nanoparticles (NPs) against 20 clinical samples of S. aureus isolated from skin exudates compared with the standard  ATCC 25923 strain investigated alone and in synergy with an antibiotic showed resistance. The most resistant isolates were selected based on being positive for MepA and Kirby and Bauer disc diffusion method. Minimum inhibitory concentration (MIC) of γ-Al2O3 NPs against S. aureus was determined within 0-360 min treatment time. Then, the double-disc synergy test (DDST) method was performed for semi-sensitive and antibiotic-resistant strains to evaluate the probable inhibitory effect in synergy form.
Results: The selected isolate expressed the MepA gene, showed the highest susceptibility reaction against γ-Al2O3 NPs in Z=78.125 ml/μg-1 and Z=156.25 ml/μg-1, and the process continued by performing the best ratio of NPs on semi-sensitive and also resistance antibiotic in synergy with NPs for the bacteria strains. The synergy of γ-Al2O3 NPs and Tetracycline, Oxacillin, and Ceftazidime showed higher sensitivity compared to using antibiotics alone. 
Conclusion: The results of this study demonstrate that γ-Al2O3 has a strong antimicrobial effect and can enhance the properties and characteristics of antibacterial potency in synergy or developed synthetic functionalized NPs with antibiotics.


1.    DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet. 2010;375(9725):1557-1568.
2.    Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352(14):1436-1444.
3.    Talan DA, Krishnadasan A, Gorwitz RJ, Fosheim GE, Limbago B, Albrecht V, et al. Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. Clin Infect Dis. 2011;53(2):144-149.
4.    Mohammadi A, Ebrahimi A, Nemati S. Bacterial and Fungal Contamination of Elevator Buttons in University Schools of Isfahan University of Medical Sciences, Isfahan, Iran. Health Scope. 2016;5(4):e34428.
5.    Morse S, F. Brooks G, C. Carroll K, S. Butel J, Mietzner T. Jawetz, Melnick & Adelberg’s Medical Microbiology. 26 ed2013.
6.    den Reijer PM, Lemmens-den Toom N, Kant S, Snijders SV, Boelens H, Tavakol M, et al. Characterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood. PLoS One. 2013;8(1):e53391.
7.    Boles BR, Horswill AR. agr-Mediated Dispersal of Staphylococcus aureus Biofilms. PLoS Pathog. 2008;4(4):e1000052.
8.    Kobayashi SD, Malachowa N, DeLeo FR. Pathogenesis of Staphylococcus aureus Abscesses. Am J Pathol. 2015;185(6):1518-1527.
9.    Kitara LD, Anywar AD, Acullu D, Odongo-Aginya E, Aloyo J, Fendu M. Antibiotic susceptibility of Staphylococcus aureus in suppurative lesions in Lacor Hospital, Uganda. Afr Health Sci. 2011;11 Suppl 1:S34-39.
10.    Kaatz GW, McAleese F, Seo SM. Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein. Antimicrob Agents Chemother. 2005;49(5):1857-1864.
11.    Ansari MA, Khan HM, Khan AA, Pal R, Cameotra SS. Antibacterial potential of Al2O3 nanoparticles against multidrug resistance strains of Staphylococcus aureus isolated from skin exudates. ‎J Nanoparticle Res. 2013;15(10):1970.
12.    Fathi Azar Khavarani M, Najafi M, Shakibapour Z, Zaeifi D. Kinetics activity of Yersinia Intermedia Against ZnO Nanoparticles Either Synergism Antibiotics by Double-Disc Synergy Test Method. Iran J Biotechnol. 2016;14(1):39-44.
13.    Shahbazi E, Moreshedzadeh F, Zaeifi D. Bacteriostatic Potency of Fe2O3 Against Enterococcus Faecalis in Synergy with Antibiotics by DDST Method. Avicenna J Med Biotechnol. 2019;11(2):176-179.
14.    Ruparelia JP, Chatterjee AK, Duttagupta SP, Mukherji S. Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater. 2008;4(3):707-716.
15.    Food U, Administration D. Division of Antiinfective and Ophthalmology Drug Products (HFD-520)—Microbiological data for antibacterial drug products—development, analysis, and presentation. FDA; 2005.
16.    Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: A review. J Pharm Anal. 2016;6(2):71-79.
17.    Jastrzębska AM, Karwowska E, Olszyna AR, Kunicki A. Influence of bacteria adsorption on zeta potential of Al2O3 and Al2O3/Ag nanoparticles in electrolyte and drinking water environment studied by means of zeta potential. SURF COAT TECH. 2015;271:225-233.
18.    Jastrzebska AM, Karwowska E, Olszyna AR, Kunicki AR. Comparative Assessment of Antimicrobial Efficiency of Ionic Silver, Silver Monoxide, and Metallic Silver Incorporated onto an Aluminum Oxide Nanopowder Carrier. J Nanosci. 2013;2013:12.
19.    Stengl V, Houšková V, Bakardjieva S, Murafa N, Maříková M, Opluštil F, et al. Zirconium doped nano-dispersed oxides of Fe, Al and Zn for destruction of warfare agents 2010. 1080–1088.
20.    Lorenz CS, Wicht A-J, Guluzada L, Luo L, Jäger L, Crone B, et al. Nano-sized Al2O3 reduces acute toxic effects of thiacloprid on the non-biting midge Chironomus riparius. PLoS One. 2017;12(5):e0176356.
21.    Nel AE, Mädler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, et al. Understanding biophysicochemical interactions at the nano–bio interface. Nat Mater. 2009;8:543.
22.    Li X, Zhou S, Fan W. Effect of Nano-Al2O3 on the Toxicity and Oxidative Stress of Copper towards Scenedesmus obliquus. Int J Environ Res Public Health. 2016;13(6):575.
23.    Jiang W, Kim BYS, Rutka JT, Chan WCW. Nanoparticle-mediated cellular response is size-dependent. Nature Nanotechnology. 2008;3:145.
24.    Raghupathi KR, Koodali RT, Manna AC. Size-Dependent Bacterial Growth Inhibition and Mechanism of Antibacterial Activity of Zinc Oxide Nanoparticles. Langmuir. 2011;27(7):4020-4028.
25.    Wu D, Chen Z, Cai K, Zhuo D, Chen J, Jiang B. Investigation into the antibacterial activity of monodisperse BSA-conjugated zinc oxide nanoparticles. CURR APPL PHYS. 2014;14(11):1470-1475.
26.    Yeaman MR, Yount NY. Mechanisms of Antimicrobial Peptide Action and Resistance. Pharmacol Rev. 2003;55(1):27.
27.    McAleese F, Petersen P, Ruzin A, Dunman PM, Murphy E, Projan SJ, et al. A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. Antimicrob Agents Chemother. 2005;49(5):1865-1871.
28.    Vinardell MP, Sordé A, Díaz J, Baccarin T, Mitjans M. Comparative effects of macro-sized aluminum oxide and aluminum oxide nanoparticles on erythrocyte hemolysis: influence of cell source, temperature, and size. J Nanoparticle Res. 2015;17(2):80.